GILEAD SCIENCES DL-,001/ US3755581036 /
05/08/2024 21:58:43 | Chg. -1.450 | Volume | Bid21:59:59 | Ask21:59:59 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
68.390EUR | -2.08% | 1,784 Turnover: 122,825.500 |
68.270Bid Size: 220 | 68.310Ask Size: 220 | 85.45 bill.EUR | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 4.54 USD | 24.04% |
EPS Diluted: | 4.50 USD | 23.63% |
Revenues per Share: | 21.76 USD | -0.52% |
Book Value per Share: | 18.26 USD | 7.36% |
Cash Flow per Share: | 6.43 USD | -11.67% |
Dividend per Share: | 3.00 USD | 2.74% |
Total | in mill. | |
Revenues: | 27,116.00 USD | -0.60% |
Net Income: | 5,665.00 USD | 23.37% |
Operating Cash Flow: | 8,006.00 USD | - |
Cash and Cash Equivalents: | 6,085.00 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 16.48 | 17.84 |
P/S Ratio: | 3.44 | 3.72 |
P/BV ratio: | 4.10 | 4.44 |
P/CF Ratio: | 11.65 | 12.61 |
PEG: | 0.69 | 0.74 |
Earnings Yield: | 6.07% | 5.60% |
Dividend Yield: | 4.01% | 3.70% |
Market Capitalization | ||
Market Capitalization: | 85.45 bill. EUR | 91.42 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | - EUR | - EUR |
Shares Outstanding: | 1.25 bill. |
Profitability
Gross Profit Margin: | 76.04% |
EBIT Margin: | 28.05% |
Net Profit Margin: | 20.89% |
Return on Equity: | 24.90% |
Return on Assets: | 9.12% |
Financial Strength
Liquidity I / Cash Ratio: | 53.95% |
Liquidity II / Quick Ratio: | 95.26% |
Liquidity III / Current Ratio: | 142.60% |
Debt / Equity Ratio: | 173.09% |
Dynam. Debt / Equity Ratio: | 491.83% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 31/12/2023 |
Accounting Standard: | US GAAP |
Currency: | USD |